dr. shaw on crizotinib in alk-positive lung cancer
Published 10 years ago • 518 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
1:52
dr. shaw on crizotinib versus chemotherapy in alk-positive nsclc
-
1:21
dr. shaw on crizotinib resistance in alk-positive lung cancer
-
1:51
dr. shaw on ldk378 in alk crizotinib-resistant nsclc patients
-
1:45
dr. shaw on using crizotinib to treat lung cancer
-
1:54
dr. shaw on monitoring crizotinib-related side effects
-
1:17
dr. christina baik on alectinib versus crizotinib in alk-positive lung cancer
-
2:26
dr. shaw on alectinib as first-line therapy in lung cancer
-
1:14
dr. shaw discusses the advent of more potent alk inhibitors
-
1:42
dr. alice shaw compares crizotinib and chemotherapy in nsclc
-
7:02
crizotinib for alk-rearranged nsclc
-
1:57
dr. shaw on sequencing strategies in alk-positive nsclc
-
42:31
alk positive lung cancer in 2023 and beyond: thinking outside the box with dr. alice shaw
-
3:04
phase iii results for alectinib compared with crizotinib in alk metastatic nsclc
-
4:00
alectinib eclipses crizotnib for alk positive lung cancer
-
2:32
dr. shaw discusses ldk378 and alectinib (af802) for alk-positive nsclc
-
1:22
dr. crinò on crizotinib in alk nsclc
-
1:35
dr. shaw on the phase iii results of the alex trial in nsclc
-
6:02
shaw patterns of resistance in alk positive nsclc
-
30:32
2023 best of lung: targeted therapies in lung cancer